SecBot SecBot

SHPH

Shuttle Pharmaceuticals Holdings, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001757499 Biotech & Drug Discovery
$4.24 −0.29 (−6.40%)
Nov 16 4:00 PM ET · prev $4.53
Market cap
$22.4M
Nano cap
1 year
−77.9%
from $19.20 · Nov 17
30 days
−10.2%
from $4.72
52-week range
$2.78–25.00
−83% from high · low Jul 29
Avg volume 20D
29.1K
Oct 23 spike 188.2K
Short interest
15.0K
≈0.3% of shares · −52.2%
Days to cover
1.0
at average volume
Insider net
−$323.1K
1 buyer · 1 seller · 12 mo
New fund stakes
0
Q4 2025 13F · 0 exits
Filing reports
9
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 1 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/3

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider bought $181.8K at an average $3.40. 1 insider sold $504.8K. Price is 25% above their cost.

  • InstitutionsMIXED

    Q4 2025: 2 added (0 new), 0 trimmed or exited.

  • Short sellersCOVERING

    Short interest −52.2% to 15.0K shares. 1.0 days to cover, ≈0.3% of shares.

  • TrendDOWNTREND

    6% below its 50-day average.

Who's buying

13F· Q4 2025
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED11,947$21.5K
BANK OF AMERICA CORP /DE/ADD12$22.00
UBS Group AGNEAR_EXIT8$28.00
BANK OF AMERICA CORP /DE/DOUBLED8$28.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Insider ledger

Form 4
$181.8K
bought · 1 insider
$504.8K
sold · 1 insider
+24.6%
vs their $3.40 cost
DateInsiderTypeValue
Jul 14, 2026
HRT FINANCIAL LP
10%+ Owner
Jul 14, 2026
SELL$367.9K
Jul 13, 2026
HRT FINANCIAL LP
10%+ Owner
Jul 13, 2026
SELL$4.8K
Jul 10, 2026
HRT FINANCIAL LP
10%+ Owner
Jul 10, 2026
BUY$2.3K
Jul 9, 2026
HRT FINANCIAL LP
10%+ Owner
Jul 9, 2026
BUY$27.9K
Jul 8, 2026
HRT FINANCIAL LP
10%+ Owner
Jul 8, 2026
SELL$65.2K
Jul 7, 2026
HRT FINANCIAL LP
10%+ Owner
Jul 7, 2026
SELL$35.2K
Jul 6, 2026
HRT FINANCIAL LP
10%+ Owner
Jul 6, 2026
SELL$31.7K
Jul 2, 2026
HRT FINANCIAL LP
10%+ Owner
Jul 2, 2026
BUY$27.8K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA· Oct 30, 2026
14,956
shares short
-52.2%
vs prior settlement
1.0
days to cover
≈0.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 6, 2026 SEC
Shuttle Pharmaceuticals dismissed Forvis Mazars, LLP as its auditor and engaged Bush & Associates CPA LLC as the new…
8-K · Impact 4/10
Oct 22, 2026 SEC
Shuttle Pharmaceuticals dismissed its auditor, Forvis Mazars, effective after the Q3 2026 10-Q filing. The dismissal…
8-K · Impact 6/10
Sep 28, 2026 Listing status
Listing Status: SHPH, Normal (was Delinquent)
Shuttle Pharmaceuticals Holdings, Inc. - common stock | Nasdaq Financial Status Indicator E → N
Sep 1, 2026 SEC
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) amended its merger agreement with United Dogecoin Inc., reducing the…
8-K · Impact 2/10
Jul 14, 2026 Insider
HRT FINANCIAL LP sold 82,116 shares
10%+ Owner @ $4.48 ($367.9K)
Jul 13, 2026 Insider
HRT FINANCIAL LP sold 1,033 shares
10%+ Owner @ $4.67 ($4.8K)
Jul 10, 2026 Insider
HRT FINANCIAL LP bought 731 shares
10%+ Owner @ $3.11 ($2.3K)
Dec 31, 2025 Inst.
UBS Group AG · DOUBLED
11,947 shares ($21.5K)

SecBot reports

9 filings · 0 bullish · 3 bearish · 6 neutral
All SHPH filing & press-release reports (9)